BIOGEN INC. DL -,0005/ US09062X1037 /
| 15.11.2024 17:25:17 | Diff. -7,00 | Volumen | Geld20:59:48 | Brief20:59:48 | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 152,30EUR | -4,39% | 130 Umsatz: 20.511,35 |
-Geld Vol: - | -Brief Vol: - | 22,17 Mrd.EUR | - | - |
Aktiva
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 2.187,6000 | 2.501,8000 | 3.182,4000 | 3.601,2000 | 3.247,3000 | ||||||
| Immaterielle Vermögensgegenstände | 4.085,1000 | 3.808,3000 | 3.879,6000 | 3.120 | 3.527,4000 | ||||||
| Finanzanlagen | 2.760,4000 | 2.829,4000 | 3.057,3000 | 1.375,9000 | 1.408,1000 | ||||||
| Anlagevermögen | 12.804,5000 | 14.144,6000 | 15.779,3000 | 17.648 | 18.852,5000 | ||||||
| Vorräte | 893,4000 | 1.001,6000 | 902,7000 | 929,9000 | 804,2000 | ||||||
| Forderungen | 1.227 | 1.441,6000 | 1.787 | 1.958,5000 | 1.880,5000 | ||||||
| Liquide Mitteln | 1.308 | 2.326,5000 | 1.573,8000 | 1.224,6000 | 2.913,7000 | ||||||
| Umlaufvermögen | 6.700,3000 | 8.732,2000 | 7.873,3000 | 7.640,9000 | 8.381,8000 | ||||||
| Aktiva, gesamt | 19.504,8000 | 22.876,8000 | 23.652,6000 | 25.288,9000 | 27.234,3000 | ||||||
Passiva
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 267,4000 | 279,8000 | 395,5000 | 370,5000 | 530,8000 | ||||||
| Langfristige Schulden | 6.521,5000 | 6.512,7000 | 5.935 | 5.936,5000 | 4.459 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 6.521,5000 | 6.512,7000 | 5.935 | 5.936,5000 | 4.459 | ||||||
| Rückstellungen | 333,6000 | 325 | 190,8000 | 1.699,7000 | 2.882,2000 | ||||||
| Verbindlichkeiten | 10.129,9000 | 10.748,2000 | 11.054,5000 | 12.257,3000 | 13.895,2000 | ||||||
| Gezeichnetes Kapital | ,1000 | ,1000 | ,1000 | ,1000 | ,1000 | ||||||
| Eigenkapital | 9.374,9000 | 12.128,6000 | 12.598,1000 | 13.031,6000 | 13.339,1000 | ||||||
| Minderheitenanteile | 2,1000 | -11,5000 | -14,7000 | -8 | -4,1000 | ||||||
| Passiva, gesamt | 19.504,8000 | 22.876,8000 | 23.652,6000 | 25.288,9000 | 27.234,3000 | ||||||
Gewinn- und Verlustrechnung
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 10.763,8000 | 11.448,8000 | 12.273,9000 | 13.452,9000 | 14.377,9000 | ||||||
| Abschreibungen (Gesamt) | 600,4000 | 682,7000 | 1.081 | 1.016,6000 | 680,6000 | ||||||
| Betriebsergebnis | 4.891 | 5.150,4000 | 5.344,2000 | 5.888,6000 | 7.042,6000 | ||||||
| Zinsergebnis | -73,4000 | -196,6000 | -172,3000 | -88,1000 | -67,4000 | ||||||
| Ergebnis vor Steuern | 4.767,3000 | 4.933 | 5.128,8000 | 5.899,6000 | 7.125,9000 | ||||||
| Ertragsteuern | 1.161,6000 | 1.237,3000 | 2.458,7000 | 1.425,6000 | 1.158 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 46,2000 | -7,1000 | 131 | 43,3000 | 0.0000 | ||||||
| Konzernjahresüberschuss | 3.547 | 3.702,8000 | 2.539,1000 | 4.430,7000 | 5.888,5000 | ||||||
Pro Aktie
Cash Flow
| 2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
2019 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 3.716,1000 | 4.522,4000 | 4.551 | 6.187,7000 | 7.078,6000 | ||||||
| Cash Flow aus Investitionstätigkeit | -4.553,6000 | -2.484,8000 | -2.963,1000 | -2.046,3000 | 470,5000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | 986,4000 | -987,8000 | -2.380 | -4.472 | -5.860,4000 | ||||||
| Veränderung der liquiden Mittel | 148,9000 | 1.049,8000 | -792,1000 | -330,6000 | 1.688,7000 | ||||||
| Anzahl der Mitarbeiter | 7.350 | 7.400 | 7.300 | 7.800 | 7.400 | ||||||
